These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7196304)

  • 21. [Degenerative type profile of cerebrospinal fluid electrophoresis in myopathies (author's transl)].
    Ben Hamida M; Mrabet A; El Younsi C
    Rev Neurol (Paris); 1982; 138(2):169-72. PubMed ID: 7100742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myoglobin abnormalities in the Duchenne type of progressive muscular dystrophy].
    Miyoshi K; Saijo K; Kuryu Y; Oshima Y; Kawai H
    Shinkei Kenkyu No Shimpo; 1965 Jul; 9(2):317-27. PubMed ID: 5894036
    [No Abstract]   [Full Text] [Related]  

  • 23. [Myoglobin and progressive muscular dystrophy].
    Sudaka P; Martin P; Rovinski J; Martin M
    Nouv Presse Med; 1972 Nov; 1(42):2838. PubMed ID: 4663746
    [No Abstract]   [Full Text] [Related]  

  • 24. Potential of radioimmunoassay of myoglobin in amniotic fluid and serum in prenatal diagnosis of Duchenne muscular dystrophy.
    Hansen KN; Lademann A; Nørgaard-Pedersen B
    Lancet; 1978 Dec; 2(8102):1250-1. PubMed ID: 82750
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of diurnal fluctuations between serum myoglobin level and creatine kinase activities in neuromuscular diseases].
    Konagaya M; Konagaya Y; Horikawa H; Takayanagi T
    Rinsho Shinkeigaku; 1984 Mar; 24(3):293-9. PubMed ID: 6540636
    [No Abstract]   [Full Text] [Related]  

  • 26. Radioimmunoassayable myoglobinaemia and Duchenne carrier detection.
    Lucci B; Dotti C; Camellini L
    Ital J Neurol Sci; 1983 Jun; 4(2):215-9. PubMed ID: 6618861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum myoglobin.
    Kagen LJ
    Arch Intern Med; 1979 Jun; 139(6):628. PubMed ID: 443964
    [No Abstract]   [Full Text] [Related]  

  • 28. [General anesthesia for progressive muscular dystrophy patients (author's transl)].
    Koshiyama K; Kuwahara O; Tanaka H; Nakashima A
    Masui; 1979 Apr; 28(4):415-20. PubMed ID: 439384
    [No Abstract]   [Full Text] [Related]  

  • 29. [The development of serum myosin light chain-III assay and evaluation in Duchenne muscular dystrophy].
    Konagaya M; Konagaya Y; Horikawa H; Honda H; Takayanagi T
    Rinsho Shinkeigaku; 1986 Aug; 26(8):783-91. PubMed ID: 3802670
    [No Abstract]   [Full Text] [Related]  

  • 30. The significance of the estimation of serum myoglobin in neuromuscular diseases.
    Hische EA; van der Helm HJ
    J Neurol Sci; 1979 Oct; 43(2):243-51. PubMed ID: 512682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on serum and urinary creatine and creatinine in progressive muscular dystrophy].
    Kondo F; Ikeda M; Abe E; Mue S
    Iryo; 1966 Jul; 20(7):694-703. PubMed ID: 5981770
    [No Abstract]   [Full Text] [Related]  

  • 32. [Genetico-clinical types of progressive muscular dystrophy (author's transl)].
    Miyoshi K
    Nihon Naika Gakkai Zasshi; 1977 Jul; 66(7):769-75. PubMed ID: 915368
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myoglobin and progressive muscular dystrophy].
    Beckmann R; von Osten V
    Dtsch Med Wochenschr; 1966 Dec; 91(50):2267-71. PubMed ID: 5332395
    [No Abstract]   [Full Text] [Related]  

  • 34. Duchenne muscular dystrophy. Morphological study of erythrocytes after treatment with L-alpha-lysophosphatidyl-choline in dystrophic patients and in the carrier state.
    Dellantonio R; Capriotti M; Angeleri F; Curatola G; Mazzanti L; Bertoli E; Lenaz G
    Acta Neurol Belg; 1981; 81(4):193-8. PubMed ID: 7293730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABNORMAL MYOGLOBIN ULTRAVIOLET SPECTRUM IN DUCHENNE TYPE OF PROGRESSIVE MUSCULAR DYSTROPHY.
    MIYOSHI K; SAIJO K; KURYU Y; OSHIMA Y
    Science; 1963 Oct; 142(3591):490-1. PubMed ID: 14064446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peculiar type of congenital muscular dystrophy (Fukuyama type) (author's transl)].
    Itagaki Y; Sakamoto Y; Nishitani Y
    Rinsho Shinkeigaku; 1980 Nov; 20(11):897-903. PubMed ID: 7249470
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serum CPK activities in long term follow up cases of progressive muscular dystrophy of Duchenne's type -with special reference to the course of disability and body weight (author's transl)].
    Konagaya M; Kohno K; Takayanagi T; Sobue I
    Rinsho Shinkeigaku; 1981 Feb; 21(2):150-7. PubMed ID: 7261497
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electrocardiographic findings in the Duchenne-type of progressive muscular dystrophy].
    Nakagawa K; Okamoto S; Goto H; Kato T; Yamamoto K
    Iryo; 1968 Dec; 22(12):1425-38. PubMed ID: 5717711
    [No Abstract]   [Full Text] [Related]  

  • 39. [Myoglobulin abnormality in Duchenne type of muscular dystrophy].
    Miyoshi K; Kuryu Y; Oshima Y; Nakano M; Kawai H
    Nihon Rinsho; 1969 Jan; 27(1):111-7. PubMed ID: 5814073
    [No Abstract]   [Full Text] [Related]  

  • 40. Morphological variations of erythrocytes in Duchenne muscular dystrophy and in carrier state.
    Capriotti M; Dellantonio R; Angeleri F; Curatola G; Mazzanti L; Bertoli E; Lenaz G; Leporoni B
    Boll Soc Ital Biol Sper; 1980 Jul; 56(14):1459-64. PubMed ID: 7448043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.